MY7900033A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- MY7900033A MY7900033A MY7900033A MY7900033A MY7900033A MY 7900033 A MY7900033 A MY 7900033A MY 7900033 A MY7900033 A MY 7900033A MY 7900033 A MY7900033 A MY 7900033A MY 7900033 A MY7900033 A MY 7900033A
- Authority
- MY
- Malaysia
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49796174A | 1974-08-16 | 1974-08-16 | |
| US55437375A | 1975-03-03 | 1975-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY7900033A true MY7900033A (en) | 1979-12-31 |
Family
ID=27052662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MY7900033A MY7900033A (en) | 1974-08-16 | 1979-12-30 | Pharmaceutical compositions |
Country Status (10)
| Country | Link |
|---|---|
| AU (1) | AU505455B2 (en) |
| CA (1) | CA1044141A (en) |
| CY (1) | CY978A (en) |
| DE (1) | DE2536349A1 (en) |
| FR (1) | FR2281757A1 (en) |
| GB (1) | GB1495034A (en) |
| HK (1) | HK73178A (en) |
| KE (1) | KE2903A (en) |
| MY (1) | MY7900033A (en) |
| NL (1) | NL7508856A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ192673A (en) * | 1979-02-02 | 1984-07-06 | Merck & Co Inc | Ophthalmic compositions for lowering intraocular pressure |
| IE50901B1 (en) * | 1980-03-04 | 1986-08-06 | Merck & Co Inc | Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure |
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
-
1975
- 1975-07-24 NL NL7508856A patent/NL7508856A/en active Search and Examination
- 1975-08-06 AU AU83713/75A patent/AU505455B2/en not_active Expired
- 1975-08-11 CY CY97875A patent/CY978A/en unknown
- 1975-08-11 GB GB3340175A patent/GB1495034A/en not_active Expired
- 1975-08-12 CA CA233,279A patent/CA1044141A/en not_active Expired
- 1975-08-14 FR FR7525408A patent/FR2281757A1/en active Granted
- 1975-08-14 DE DE19752536349 patent/DE2536349A1/en not_active Ceased
-
1978
- 1978-11-15 KE KE290378A patent/KE2903A/en unknown
- 1978-12-14 HK HK73178A patent/HK73178A/en unknown
-
1979
- 1979-12-30 MY MY7900033A patent/MY7900033A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2536349A1 (en) | 1976-02-26 |
| FR2281757B1 (en) | 1980-04-11 |
| CY978A (en) | 1979-03-23 |
| CA1044141A (en) | 1978-12-12 |
| KE2903A (en) | 1978-12-01 |
| AU8371375A (en) | 1977-02-10 |
| GB1495034A (en) | 1977-12-14 |
| NL7508856A (en) | 1976-02-18 |
| AU505455B2 (en) | 1979-11-22 |
| FR2281757A1 (en) | 1976-03-12 |
| HK73178A (en) | 1978-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KE3052A (en) | Pharmaceutical compositions | |
| NZ179495A (en) | 1-substituted-4-benzylpiperidines and pharmaceutical compositions | |
| ZA74385B (en) | Pharmaceutical compositions | |
| ZA756572B (en) | Shampoo compositions | |
| ZA755998B (en) | Pharmaceutical compositions | |
| IL48508A (en) | Pharmaceutical compositions comprising piperidylindole derivatives | |
| AU487061B2 (en) | Pharmaceutical compositions | |
| PH12058A (en) | Antibiotic pharmaceutical compositions | |
| IL46965A (en) | Pharmaceutical composition containing heparinoidic factor | |
| IL47681A0 (en) | Uv-photopolymerizable compositions | |
| HK17281A (en) | Pharmaceutical compositions | |
| NZ179502A (en) | Ii-desoxy-omega-tetra norprostaglanding internediates pharmaceutical composition | |
| ZA755802B (en) | Pharmaceutical compositions | |
| IL48098A0 (en) | Pharmaceutical compositions containing diphenylethanol derivatives | |
| PH12855A (en) | Pharmaceutical compositions | |
| MY7900033A (en) | Pharmaceutical compositions | |
| MW5275A1 (en) | Compositions | |
| ZA755515B (en) | Pharmaceutical formulations | |
| NZ178962A (en) | 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions | |
| ZA757067B (en) | Pharmaceutical compositions comprising substituted 4,6-dihydroxy-2h-pyran-2-ones | |
| ZA742246B (en) | Pharmaceutical compositions | |
| ZA744340B (en) | Pharmaceutical compositions | |
| IE39123B1 (en) | Pharmaceutical compositions | |
| ZA756921B (en) | Pharmaceutical compositions | |
| ZA755904B (en) | Pharmaceutical compositions |